Abstract:Wilson disease (WD), is a rare autosomal recessive inherited disease involving copper metabolism disturbance due to the mutations of ATP7B gene that encodes the P‐type ATPase. Early diagnosis and intervention of WD are critical to limit disease progression, and the disease is lethal if the patients is not treated early. The detection of ATP7B gene mutation may be powerful tools for WD accurately diagnosis, especially for patients who have mild to moderate disease. Therefore, we recruited 18 WD Chinese patients and their 43 first‐degree relatives from 16 families and 2 independent individuals for DNA sequencing to systematically analyze the genotypes of Chinese WD patients. We also conducted a series of experiments to elucidation of possible functional consequences of these ATP7B mutations. A total of 33 ATP7B gene variants were identified, including three variants with uncertain significance (VUS) [two splice mutations (c.51+2T>G, c.1543+40G>A) and one frameshift mutation (c.3532_3535del)]. The CCK‐8 and apoptosis assays demonstrated that the VUS of ATP7B could significantly affect the transportation of copper. Our study enriches the mutation spectrum of the ATP7B gene worldwide and provides valuable reference data for studying the mutation type and genetic mode of ATP7B in the Chinese population.ObjectivesWilson disease (WD) is a rare autosomal recessive genetic disorder associated with various mutations in the ATP7B gene and leads to significant disability or death if untreated. Early diagnosis and proper therapy usually predict a good prognosis, especially in pre‐symptomatic WD. Genetic testing provides an accurate and effective diagnostic method for the early diagnosis of WD.MethodsWe recruited 18 clinically diagnosed WD patients from 16 unrelated families and two independent individuals. The next‐generation sequencing of the ATP7B gene was performed. The 293T cell lines were divided into wild‐type (WT) ATP7B and mutated ATP7B groups. Cell proliferation was determined by Cell Counting Kit‐8 (CCK‐8) assay and apoptosis was detected by Annexin V/propidium iodide (PI) assays.ResultsPedigree analysis showed that compound heterozygous variants (17/18, 94.44%) were present in the majority of WD patients. A total of 33 ATP7B gene variants were identified, including three variants with uncertain significance (VUS) [two splice mutations (c.51+2T>G, c.1543+40G>A) and one frameshift mutation (c.3532_3535del)]. The CCK‐8 and apoptosis assays demonstrated that the VUS of ATP7B could significantly affect the transportation of copper.ConclusionsThe study revealed genetic defects of 16 Chinese families and two independent individuals with WD, which enriched the mutation spectrum of the ATP7B gene worldwide and provided valuable information for studying the mutation types of ATP7B in the Chinese populations. Genetic testing in WD patients is necessary to shorten the time to initiate therapy, reduce damage to the liver and improve the prognosis.

A clinical study showing the expression characteristics of cuproptosis markers in cases with Wilson disease

Population Screening and Diagnostic Strategies in Screening Family Members of Wilson’s Disease Patients

Hemolytic Anemia As First Presentation of Wilson's Disease with Uncommon ATP7B Mutation.

[Progress in molecular mechanism of hepatolenticular degeneration induced by ATP7B gene mutation]

Wilson Disease: Identification of Two Novel Mutations and Clinical Correlation in Eastern Chinese Patients

Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update

Phenotypic and genetic characterization of children with Wilson Disease from Northeast China

Macrothrombocytopenia with leukocyte inclusions in a patient with Wilson disease: a case report and literature review

Wilson’s Disease in China

Aberrant copper metabolism and hepatic inflammation cause neurological manifestations in a mouse model of Wilson's disease

Correlation of clinical features of Wilson's disease with ATP7B gene mutation in children

Advance in the Pathogenesis and Treatment of Wilson Disease

[Progress in drug therapy of Wilson's disease]

Identification of potential modifier genes in Chinese patients with Wilson disease

Epidemiology of Wilson's Disease and Pathogenic Variants of the ATP7B Gene Leading to Diversified Protein Disfunctions

Systemic deletion of Atp7b modifies the hepatocytes’ response to copper overload in the mouse models of Wilson disease

Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson’s Disease

Advance in the Pathogenesis and Treatment Of

Genetic studies discover novel coding and non‐coding mutations in patients with Wilson's disease in China

Identification and characterization of a novel 43-bp deletion mutation of the ATP7B gene in a Chinese patient with Wilson's disease: a case report

Novel mutations of the ATP7B gene in Han Chinese families with pre-symptomatic Wilson's disease